AstraZeneca rejects Pfizer bid as inadequate By: MarketWatch May 02, 2014 at 06:36 AM EDT AstraZeneca says an improved takeover offer from Pfizer worth more than $106 billion substantially undervalues the company. Read More >> Related Stocks: Astrazeneca Plc ADR Macy's Pfizer